ST Structure Therapeutics Inc. Stock: price and management transactions · United States · SEC (Form 4)Follow the Structure Therapeutics Inc. share price and the full management transaction log of the company, a listed issuer based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €3.8bn. The latest transaction was reported on 7 August 2026 (Attribution). Among the most active insiders: Lin Xichen. Every trade is accessible without an account.
Analyst consensus: bullish or bearish? Analysts rate Structure Therapeutics Inc. Strong Buy (bullish), based on 15 analysts. Average price target: US$104.77.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 August 2026
All Executives49 Thresholds0 Prospectus0 Other0
Declarations 49 total
◆ Chief Commercial Officer · Executives · 6 Aug 2026
140,766 shares 0Ordinary Shares SEC:0002148420-26-000006:0
● CHIEF SCIENTIFIC OFFICER · Executives · 4 Aug 2026
11,817 shares 0Ordinary Shares SEC:0001962926-26-000007:1
◇ CHIEF SCIENTIFIC OFFICER · Executives · 4 Aug 2026
11,817 shares @ US$0.34 0.0001% mcap 0.7% of flow Ordinary Shares SEC:0001962926-26-000007:0
◇ CHIEF SCIENTIFIC OFFICER · Executives · 14 Jul 2026
23,634 shares @ US$0.34 0.0002% mcap 1.4% of flow Ordinary Shares SEC:0001962926-26-000006:0
● CHIEF SCIENTIFIC OFFICER · Executives · 14 Jul 2026
23,634 shares 0Ordinary Shares SEC:0001962926-26-000006:1
● Officer · Executives · 25 Jun 2026
35,512 shares @ US$48.16 0.044% mcap 100.0% of flow Common SEC144:0001950047-26-006512
◆ COO & GC · Executives · 15 Apr 2026
184,614 shares 0Ordinary Shares SEC:0001712069-26-000007:0
◆ CHIEF SCIENTIFIC OFFICER · Executives · 19 Mar 2026
43,368 shares 0Ordinary Shares SEC:0001962926-26-000003:0
◆ CHIEF MEDICAL OFFICER · Executives · 19 Mar 2026
75,897 shares 0Ordinary Shares SEC:0002037144-26-000003:0
◆ CHIEF TECHNOLOGY OFFICER · Executives · 19 Mar 2026
32,526 shares 0Ordinary Shares SEC:0001963664-26-000003:0
◆ CHIEF FINANCIAL OFFICER · Executives · 19 Mar 2026
104,085 shares 0Ordinary Shares SEC:0001962414-26-000003:0
◆ Chief Development Officer · Executives · 19 Mar 2026
47,706 shares 0Ordinary Shares SEC:0001801842-26-000003:0
◆ CHIEF EXECUTIVE OFFICER · Executives · 19 Mar 2026
260,217 shares 0Ordinary Shares SEC:0001698149-26-000003:0
● CHIEF TECHNOLOGY OFFICER · Executives · 3 Mar 2026
11,313 shares @ US$20.99 83.6% of flow Ordinary Shares SEC:0001963664-26-000002:0
● CHIEF SCIENTIFIC OFFICER · Executives · 3 Mar 2026
18,735 shares @ US$20.99 68.2% of flow Ordinary Shares SEC:0001962926-26-000002:0
● Chief Development Officer · Executives · 3 Mar 2026
4,836 shares @ US$20.99 68.7% of flow Ordinary Shares SEC:0001801842-26-000002:0
● CHIEF EXECUTIVE OFFICER · Executives · 3 Mar 2026
53,454 shares @ US$20.99 88.0% of flow Ordinary Shares SEC:0001698149-26-000002:0
● CHIEF MEDICAL OFFICER · Executives · 3 Mar 2026
11,826 shares @ US$20.99 77.2% of flow Ordinary Shares SEC:0002037144-26-000002:0
● CHIEF FINANCIAL OFFICER · Executives · 3 Mar 2026
22,305 shares @ US$20.99 89.8% of flow Ordinary Shares SEC:0001962414-26-000002:0
● CHIEF MEDICAL OFFICER · Executives · 18 Sept 2025
8,106 shares @ US$7.7433 85.0% of flow Ordinary Shares SEC:0002037144-25-000003:0
● Chief Development Officer · Executives · 18 Sept 2025
6,021 shares @ US$7.7433 100.0% of flow Ordinary Shares SEC:0001801842-25-000004:0
● CHIEF TECHNOLOGY OFFICER · Executives · 1 Jul 2025
4,470 shares @ US$6.8366 65.1% of flow Ordinary Shares SEC:0001415889-25-022472:0
● CHIEF SCIENTIFIC OFFICER · Executives · 1 Jul 2025
12,846 shares @ US$6.8366 47.5% of flow Ordinary Shares SEC:0001415889-25-022471:0
● CHIEF MEDICAL OFFICER · Executives · 1 Mar 2025
1,233 shares @ US$7.9166 100.0% of flow Ordinary Shares SEC:0001415889-25-019354:0
● CHIEF TECHNOLOGY OFFICER · Executives · 1 Mar 2025
1,824 shares @ US$7.9166 100.0% of flow Ordinary Shares SEC:0001415889-25-019353:0
25 of 49 declarations
Load more (24 remaining) 关于 Structure Therapeutics Inc. Structure Therapeutics Inc. 是一家生物制药公司，专注于开发代谢疾病和健康相关疾病的治疗方法。该公司采用药物发现平台来识别新疗法。